A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer.
Clinical trial NCT05004350 · COMPLETED
Trial details
- NCT number
- NCT05004350
- Sponsor
- Pierre Fabre Medicament
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-14
- Primary completion
- 2023-12-19
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.